Evidence map›Paper›PMID 40491447›Full record

ReviewFrontiers in physiology2025

Emerging roles of pyruvate dehydrogenase phosphatase 1: a key player in metabolic health.

Vikalp Kumar, Miriam L Greenberg

Abstract readReview
In one paragraph

Review in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Mitochondrial CaNature metabolism · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vikalp KumarDepartment of Biological Sciences, Wayne State University, Detroit, MI, United States.
Miriam L GreenbergDepartment of Biological Sciences, Wayne State University, Detroit, MI, United States.

Funding

THE ROLE OF CARDIOLIPIN IN THE TCA CYCLE: IMPLICATIONS FOR BARTH SYNDROMER01HL117880 · NHLBI · WAYNE STATE UNIVERSITY · PI GREENBERG, MIRIAM L · 2014 to 2023
$3.0M
Selective inhibitors of MLCL/CytC Peroxidase in Barth SyndromeR01HL174611 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Hülya Bayir, Miriam L Greenberg · 2024 to 2026
$2.1M
NHLBI NIH HHS R01 HL117880NHLBI NIH HHS R01 HL174611
6 · The paper itself

Abstract

Pyruvate dehydrogenase phosphatase (PDP), a structurally conserved member of the protein phosphatase C family (PP2C) of proteins, is a key regulatory enzyme responsible for reactivation of the mitochondrial gate-keeper, pyruvate dehydrogenase (PDH). Tissue-specific expression of PDP isozymes, specifically PDP1 and PDP2 facilitate regulation of the multi-subunit PDH, influencing flux of substrates to the TCA cycle. PDP1 is a heterodimeric, Ca

Indexed as

barth syndromecancercardiomyogenesispyruvate dehydrogenase complexpyruvate dehydrogenase phosphatase 1traumatic brain injury

Identifiers

PMID40491447
PMCPMC12146199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.